Adrian Gabriel Torres

Background

About Adrian Gabriel Torres

Senior scientific leader with 15+ years of experience in fundamental research, translational science, and drug development. Combining deep technical expertise in RNA therapeutics with strategic R&D leadership. Committed to scientific excellence, execution, and long-term value creation. SCIENTIFIC & TRANSLATIONAL EXPERTISE- RNA therapeutics, antisense technologies, aptamer-based targeted therapies- Rare disease programs: neuromuscular disorders and paediatric oncology- Chemical modification and drug/ligand conjugation of oligonucleotides- Non-coding RNA biology and functional genomics.STRATEGIC IMPACT- Science-driven corporate growth: exploiting internal capabilities and carefully fostering and leading partnerships across academia, biotechs, hospitals, and foundations- Successful capital raising: leading and securing non-dilutive funding through competitive national and international grants, and supporting dilutive rounds through scientific engagement with investors- Strong scientific credibility: built on high-impact peer-reviewed publications, international presentations to scientific, clinical, and investment audiences, and contributions to externally reviewed scientific programs- Scientific talent empowering: for their growth and success, by fostering a culture of trust and accountability, leading by example and promoting a clear and candid communication- Collaborative and approachable executive: efficiently working with C-level management, the board, and external stakeholders to enable smooth decision-making and operational continuity.VISION To continuously translate science into life quality improvements with passion, curiosity and professionalism.Motivated by environments that value dedication and strong performance, scientific rigor, open and transparent communication, and leadership with empathy.